Another study showed that inhibition of GRP78 increases the sensitivity of colorectal cancer cells to chemotherapeutics such as 5-fluorouracil (5-FU) and oxaliplatin, improving the response to treatment and promoting apoptosis of cancer cells. This evidence concerns the gene HSPA5 and cancer.